- Bloomberg•14 hours ago
England is reopening its Cancer Drugs Fund with a crafty solution to rein in the overspending that blighted its predecessor: make drugmakers pay.
- Market Realist•2 days ago
After the earnings results, analysts updated Roche's consensus 12-month target price to $36.85 from the $37.2 pre-earnings price.
|Day's Range||0.00 - 0.00|
|Avg Vol (3m)||986,342|
As of 3:59 PM EDT. Market closed.